LECLEC,INC.7874東証プライム化学FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥6 is left as operating profit. Revenue changed +3.0% from the prior year, operating profit +48.8%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 4.4% | 0.69× | 3.1% | 2.34× | 7.1% |
| 2023 | 1.7% | 0.70× | 1.2% | 2.48× | 2.9% |
| 2024 | 1.3% | 0.70× | 0.9% | 2.69× | 2.5% |
| 2025 | 2.5% | 0.74× | 1.9% | 2.85× | 5.3% |
| 2026 | 4.4% | 0.75× | 3.3% | 2.91× | 9.5% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 51,423 | 55,461 | 60,783 | 66,304 | 68,294 |
| Cost of revenue | 34,702 | 40,864 | 44,590 | 48,878 | 47,605 |
| Gross profit | 16,720 | 14,597 | 16,193 | 17,426 | 20,688 |
| SG&A | 13,513 | 13,686 | 14,564 | 14,645 | 16,551 |
| Operating income | 3,206 | 911 | 1,628 | 2,780 | 4,136 |
| Pretax income | 3,530 | 1,796 | 1,681 | 2,318 | 4,486 |
| Income tax | 1,145 | 712 | 697 | 634 | 1,472 |
| Net income attributable to owners | 2,282 | 942 | 796 | 1,667 | 2,978 |
| Operating margin | 6.2% | 1.6% | 2.7% | 4.2% | 6.1% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥11.5B | ¥14.4B | ¥20.4B | ¥13.7B | ¥24.2B |
| Total assets | ¥74.6B | ¥84.3B | ¥89.2B | ¥88.9B | ¥93.8B |
| Net assets | ¥35.8B | ¥36.3B | ¥37.6B | ¥36B | ¥38.8B |
| Share capital | ¥5.49B | ¥5.49B | ¥5.49B | ¥5.49B | ¥5.49B |
| Trade receivables | ¥8.05B | ¥9.71B | ¥10.7B | ¥10.9B | ¥10.5B |
| Property, plant and equipment | ¥25.7B | ¥24.9B | ¥23.3B | ¥20.7B | ¥20B |
| Intangible assets excluding goodwill | ¥953M | ¥683M | ¥465M | ¥2.43B | ¥2.22B |
| Goodwill | ¥265M | ¥117M | ¥4M | ¥1.15B | ¥1.02B |
| Investment securities | ¥4.19B | ¥5.03B | ¥6.64B | ¥9.03B | ¥10.8B |
| Current assets | ¥41.7B | ¥52.2B | ¥57.5B | ¥55.4B | ¥59.1B |
| Current liabilities | ¥12.1B | ¥11.5B | ¥12.1B | ¥9.76B | ¥14.4B |
| Trade payables | ¥2.48B | ¥2.29B | ¥2.24B | ¥2.63B | ¥2.55B |
| Short-term borrowings | ¥200M | ¥200M | ¥400M | — | ¥1B |
| Long-term borrowings | ¥25.2B | ¥34.1B | ¥37B | ¥40.9B | ¥37.8B |
| Total liabilities | ¥38.8B | ¥48B | ¥51.6B | ¥52.9B | ¥55B |
| Non-controlling interests | ¥1.57B | ¥1.64B | ¥1.83B | ¥1.41B | ¥1.12B |
| Equity attributable to owners of parent | ¥31.9B | ¥32.2B | ¥32.4B | ¥30.2B | ¥32.6B |
| Retained earnings | ¥21.4B | ¥21.6B | ¥21.7B | ¥22.7B | ¥25B |
| Treasury stock | -¥2.24B | -¥2.11B | -¥1.97B | -¥5.37B | -¥5.13B |
EDINET (FSA Japan)
有価証券報告書－第44期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第43期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第42期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第41期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第40期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第39期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 55 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.